Market Blog » The Arora Report Stock Market News

TAKE PROFITS ON MARVELL TECHNOLOGY AND EXIT THE POSITION

November 9, 2020

The semiconductor company Marvell Technology Group (MRVL) was bought at $35.33 eight trading days ago. Partial profits have already been taken. MRVL traded as high as $45.82 on Friday. The low band of the medium-term target was $46. Since the gains happened in a very short time, consider taking profits in the zone of $42.75 to $46 and exit the position. Consider entering it again if it dips into the buy zone. This post was just published on ZYX Buy Change Alert. A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO

VERY EFFECTIVE COVID-19 VACCINE — HERE IS THE GAME PLAN FOR PRUDENT INVESTORS NOW

November 9, 2020

To gain an edge, this is what you need to know today. Reduce Cash And Hedges Both cash and hedge levels are being reduced. It is best to make the transition in several steps — some now and more on the dips. Vaccine Vaccine data from Pfizer (PFE) and BioNTech (BNTX) has shown 90% efficacy. FDA has been willing to approve efficacy of 50%. Most expectations have been for efficacy of less than 70% The news is much better than expected. Many hurdles still remain. Breakout Above The Magnet Please click here for a chart of S&P 500 ETF (SPY)

NEW BUY ZONES ON 39 STOCKS — WITH BUY ZONES YOU COULD HAVE DOUBLED YOUR MONEY IN APPLE IN FOUR MONTHS

November 8, 2020

Buy zones are very powerful. When a stock dips into the buy zone you buy it. If you were following the buy zones, you could have more than doubled your money in Apple (AAPL) stock. Earlier in 2020, Apple dipped into the buy zone as low as $53.01. Since then Apple stock has traded as high as $137.98. This represents a return of 160% in a matter of months. With the help of buy zones, you could have bought Microsoft (MSFT) stock as low as $132.52 . Since then Microsoft stock has traded as high as $232.86. Please click here

SPECTACULAR JOBS CREATION, TRUMP AND GEORGIA MAY GET IN THE WAY

November 7, 2020

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report. Please scroll down for the section ‘Protection Bands and What To Do Now.’ SPECTACULAR JOBS CREATION, TRUMP AND GEORGIA MAY GET IN THE WAY November 6, 2020 To gain an edge, this is what you need

BIDEN STOCK MARKET RALLY — FED READY TO PRINT MORE MONEY

November 6, 2020

To gain an edge, this is what you need to know now. The Chart Please click here for a chart of S&P 500 ETF (SPY) which represents stock market benchmark index (SPX). Note the following: The chart shows the big stock market rally in the morning to celebrate the potential Biden victory. The rally was in line with the move up earlier in futures. Before going further, take another look at the magnet that traders are drawn to shown in the chart here. For details read the Morning Capsule. The VUD indicator is the most sensitive measure of net supply

A NEW PROMISING DRUG FOR ALZHEIMER’S — OPPORTUNITY FOR INVESTORS

November 5, 2020

Alzheimer’s Alzheimer’s is a terrible disease. A new patient is diagnosed with Alzheimer’s in the United States every 65 seconds. More than 5.8 million Americans are living with Alzheimer’s. For those who are over 65, one in 10 has Alzheimer’s dementia. There is no cure. Now a new treatment is on the horizon. If the treatment works, can you imagine the investment potential? New Drug FDA Advisory Committee panel sees ‘substantial evidence’ for approval of Alzheimer’s drug from Biogen (BIIB). BIIB is in the Arora Report Portfolio. We previously wrote: If the drug ultimately works and is approved, BIIB may ultimately

PRUDENT INVESTORS: HERE ARE THE ‘MUST KNOW’ TAKE AWAYS FROM THE ELECTION SO FAR

November 4, 2020

To gain an edge, this is what you need to know today. Election Here are the key points: There was no blue wave. There was a red wave in some areas of the country. Pollsters were wrong. The media was wrong. A vast majority of analysts were wrong. The Good News There is a lot of good news for The Arora Report subscribers based on what is known so far. Arora portfolios are almost perfectly positioned for what is likely emerging from the election. No big changes are likely needed for the portfolios. Mistakes Avoided Markets move fast, they are

WALL STREET BUYING BIDEN STOCKS SUCH AS MARIJUANA AND SELLING TRUMP STOCKS

November 3, 2020

To gain an edge, this is what you need to know now. Apolitical First and foremost, a reminder that The Arora Report is apolitical. Our sole job is to help investors. Successful investors separate their politics from their investments. The objective is to make money under all conditions. For background, if you have not already read, please first read: PRUDENT INVESTORS PAY ATTENTION: ELECTION ANALYSIS FROM THE ANALYST WHO CALLED TRUMP VICTORY IN 2016 AND STOCK MARKET RISE. Heavy Buying In Biden Stocks Please click here for a chart of Canopy Growth Corporation (CGC). Note the following: In the Morning